171 related articles for article (PubMed ID: 11470758)
1. Antiproliferative B cell translocation gene 2 protein is down-regulated post-transcriptionally as an early event in prostate carcinogenesis.
Ficazzola MA; Fraiman M; Gitlin J; Woo K; Melamed J; Rubin MA; Walden PD
Carcinogenesis; 2001 Aug; 22(8):1271-9. PubMed ID: 11470758
[TBL] [Abstract][Full Text] [Related]
2. Cisplatin modulates B-cell translocation gene 2 to attenuate cell proliferation of prostate carcinoma cells in both p53-dependent and p53-independent pathways.
Chiang KC; Tsui KH; Chung LC; Yeh CN; Feng TH; Chen WT; Chang PL; Chiang HY; Juang HH
Sci Rep; 2014 Jul; 4():5511. PubMed ID: 24981574
[TBL] [Abstract][Full Text] [Related]
3. BTG2 loss and miR-21 upregulation contribute to prostate cell transformation by inducing luminal markers expression and epithelial-mesenchymal transition.
Coppola V; Musumeci M; Patrizii M; Cannistraci A; Addario A; Maugeri-Saccà M; Biffoni M; Francescangeli F; Cordenonsi M; Piccolo S; Memeo L; Pagliuca A; Muto G; Zeuner A; De Maria R; Bonci D
Oncogene; 2013 Apr; 32(14):1843-53. PubMed ID: 22614007
[TBL] [Abstract][Full Text] [Related]
4. L-Mimosine blocks cell proliferation via upregulation of B-cell translocation gene 2 and N-myc downstream regulated gene 1 in prostate carcinoma cells.
Chung LC; Tsui KH; Feng TH; Lee SL; Chang PL; Juang HH
Am J Physiol Cell Physiol; 2012 Feb; 302(4):C676-85. PubMed ID: 22116304
[TBL] [Abstract][Full Text] [Related]
5. Identification of genes associated with stromal hyperplasia and glandular atrophy of the prostate by mRNA differential display.
Walden PD; Lefkowitz GK; Ficazzola M; Gitlin J; Lepor H
Exp Cell Res; 1998 Nov; 245(1):19-26. PubMed ID: 9828097
[TBL] [Abstract][Full Text] [Related]
6. Triiodothyronine modulates cell proliferation of human prostatic carcinoma cells by downregulation of the B-cell translocation gene 2.
Tsui KH; Hsieh WC; Lin MH; Chang PL; Juang HH
Prostate; 2008 May; 68(6):610-9. PubMed ID: 18196550
[TBL] [Abstract][Full Text] [Related]
7. TIS21 (/BTG2/PC3) as a link between ageing and cancer: cell cycle regulator and endogenous cell death molecule.
Lim IK
J Cancer Res Clin Oncol; 2006 Jul; 132(7):417-26. PubMed ID: 16456675
[TBL] [Abstract][Full Text] [Related]
8. 14-3-3sigma is down-regulated in human prostate cancer.
Urano T; Takahashi S; Suzuki T; Fujimura T; Fujita M; Kumagai J; Horie-Inoue K; Sasano H; Kitamura T; Ouchi Y; Inoue S
Biochem Biophys Res Commun; 2004 Jul; 319(3):795-800. PubMed ID: 15184053
[TBL] [Abstract][Full Text] [Related]
9. Expression of B-cell translocation gene 2 protein in normal human tissues.
Melamed J; Kernizan S; Walden PD
Tissue Cell; 2002 Feb; 34(1):28-32. PubMed ID: 11989967
[TBL] [Abstract][Full Text] [Related]
10. Androgen-regulated miR-32 targets BTG2 and is overexpressed in castration-resistant prostate cancer.
Jalava SE; Urbanucci A; Latonen L; Waltering KK; Sahu B; Jänne OA; Seppälä J; Lähdesmäki H; Tammela TL; Visakorpi T
Oncogene; 2012 Oct; 31(41):4460-71. PubMed ID: 22266859
[TBL] [Abstract][Full Text] [Related]
11. Topoisomerase inhibitors modulate gene expression of B-cell translocation gene 2 and prostate specific antigen in prostate carcinoma cells.
Chiang KC; Tsui KH; Chung LC; Yeh CN; Chang PL; Chen WT; Juang HH
PLoS One; 2014; 9(2):e89117. PubMed ID: 24586533
[TBL] [Abstract][Full Text] [Related]
12. A systematic search for downstream mediators of tumor suppressor function of p53 reveals a major role of BTG2 in suppression of Ras-induced transformation.
Boiko AD; Porteous S; Razorenova OV; Krivokrysenko VI; Williams BR; Gudkov AV
Genes Dev; 2006 Jan; 20(2):236-52. PubMed ID: 16418486
[TBL] [Abstract][Full Text] [Related]
13. Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis.
De Marzo AM; Marchi VL; Epstein JI; Nelson WG
Am J Pathol; 1999 Dec; 155(6):1985-92. PubMed ID: 10595928
[TBL] [Abstract][Full Text] [Related]
14. Polycyclic aromatic hydrocarbon carcinogens increase ubiquitination of p21 protein after the stabilization of p53 and the expression of p21.
Nakanishi Y; Pei XH; Takayama K; Bai F; Izumi M; Kimotsuki K; Inoue K; Minami T; Wataya H; Hara N
Am J Respir Cell Mol Biol; 2000 Jun; 22(6):747-54. PubMed ID: 10837373
[TBL] [Abstract][Full Text] [Related]
15. Translational downregulation of Twist1 expression by antiproliferative gene, B-cell translocation gene 2, in the triple negative breast cancer cells.
Devanand P; Sundaramoorthy S; Ryu MS; Jayabalan AK; Ohn T; Lim IK
Cell Death Dis; 2019 May; 10(6):410. PubMed ID: 31138781
[TBL] [Abstract][Full Text] [Related]
16. BTG2 is an LXXLL-dependent co-repressor for androgen receptor transcriptional activity.
Hu XD; Meng QH; Xu JY; Jiao Y; Ge CM; Jacob A; Wang P; Rosen EM; Fan S
Biochem Biophys Res Commun; 2011 Jan; 404(4):903-9. PubMed ID: 21172304
[TBL] [Abstract][Full Text] [Related]
17. B cell translocation gene 2 enhances susceptibility of HeLa cells to doxorubicin-induced oxidative damage.
Lim YB; Park TJ; Lim IK
J Biol Chem; 2008 Nov; 283(48):33110-8. PubMed ID: 18840609
[TBL] [Abstract][Full Text] [Related]
18. Identification of BTG2, an antiproliferative p53-dependent component of the DNA damage cellular response pathway.
Rouault JP; Falette N; Guéhenneux F; Guillot C; Rimokh R; Wang Q; Berthet C; Moyret-Lalle C; Savatier P; Pain B; Shaw P; Berger R; Samarut J; Magaud JP; Ozturk M; Samarut C; Puisieux A
Nat Genet; 1996 Dec; 14(4):482-6. PubMed ID: 8944033
[TBL] [Abstract][Full Text] [Related]
19. BTG2 is a tumor suppressor gene upregulated by p53 and PTEN in human bladder carcinoma cells.
Tsui KH; Chiang KC; Lin YH; Chang KS; Feng TH; Juang HH
Cancer Med; 2018 Jan; 7(1):184-195. PubMed ID: 29239139
[TBL] [Abstract][Full Text] [Related]
20. Role of p27 in prostate carcinogenesis.
Macri E; Loda M
Cancer Metastasis Rev; 1998-1999; 17(4):337-44. PubMed ID: 10453277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
